Kenvue, Inc. (KVUE) Receives a Hold from RBC Capital
RBC Capital analyst Nik Modi maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $24.00. The ...
Hosted on MSN11h
Gear Up for Kenvue (KVUE) Q4 Earnings: Wall Street Estimates for Key Metrics
In its upcoming report, Kenvue (KVUE) is predicted by Wall Street analysts to post quarterly earnings of $0.25 per share, reflecting a decline of 19.4% compared to the same period last year. Revenues ...
Kenvue's SWOT analysis: stock faces headwinds amid strategic shift
Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson in 2023, finds itself at a critical juncture as it navigates its first full year as an independent entity. The ...
Kenvue (KVUE) Expected to Announce Quarterly Earnings on Thursday
Kenvue (NYSE:KVUE – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on ...
Barclays Remains a Hold on Kenvue, Inc. (KVUE)
Barclays analyst Lauren Lieberman maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $21.00. The ...
Nasdaq4d
Kenvue (KVUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Kenvue (KVUE) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives ...
Barchart on MSN10d
What You Need to Know Ahead of Kenvue's Earnings Release
Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a consumer health company worldwide. Valued at $39.8 billion by ...
Hosted on MSN3d
Is Wall Street Bullish or Bearish on Kenvue Stock?
Kenvue Inc. (KVUE), a global consumer health company, is dedicated to delivering trusted personal care, health, and wellness ...